ColgatePalmolive (CL)
(Delayed Data from NYSE)
$89.29 USD
+0.42 (0.47%)
Updated Apr 25, 2024 04:00 PM ET
Pre-Market: $91.15 +1.86 (2.08%) 8:42 AM ET
2-Buy of 5 2
D Value B Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for ColgatePalmolive Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 966 | 775 | 832 | 888 | 883 |
Receivables | 1,586 | 1,504 | 1,297 | 1,264 | 1,440 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,934 | 2,074 | 1,692 | 1,673 | 1,400 |
Other Current Assets | 793 | 760 | 576 | 513 | 456 |
Total Current Assets | 5,279 | 5,113 | 4,397 | 4,338 | 4,179 |
Net Property & Equipment | 4,582 | 4,307 | 3,730 | 3,716 | 3,750 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 214 | 135 | 193 | 291 | 177 |
Intangibles | 5,297 | 5,272 | 5,746 | 6,718 | 6,175 |
Deposits & Other Assets | 1,021 | 904 | 974 | 857 | 753 |
Total Assets | 16,393 | 15,731 | 15,040 | 15,920 | 15,034 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 310 | 11 | 39 | 258 | 260 |
Accounts Payable | 1,698 | 1,551 | 1,479 | 1,393 | 1,237 |
Current Portion Long-Term Debt | 20 | 14 | 12 | 9 | 254 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2,377 | 2,111 | 2,085 | 2,341 | 1,917 |
Income Taxes Payable | 336 | 317 | 436 | 403 | 370 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4,741 | 4,004 | 4,051 | 4,404 | 4,038 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 361 | 383 | 395 | 426 | 507 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 8,219 | 8,741 | 7,194 | 7,334 | 7,333 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2,115 | 1,797 | 2,429 | 2,655 | 2,598 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 15,436 | 14,925 | 14,069 | 14,819 | 14,476 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,466 | 1,466 | 1,466 | 1,466 | 1,466 |
Capital Surplus | 3,808 | 3,546 | 3,269 | 2,969 | 2,488 |
Retained Earnings | 25,289 | 24,573 | 24,350 | 23,699 | 22,501 |
Other Equity | -3,589 | -3,651 | -4,025 | -3,988 | -3,834 |
Treasury Stock | 26,017 | 25,128 | 24,089 | 23,045 | 22,063 |
Total Shareholder's Equity | 957 | 806 | 971 | 1,101 | 558 |
Total Liabilities & Shareholder's Equity | 16,393 | 15,731 | 15,040 | 15,920 | 15,034 |
Total Common Equity | 957 | 806 | 971 | 1,101 | 558 |
Shares Outstanding | 823.30 | 835.20 | 842.80 | 857.10 | 857.00 |
Book Value Per Share | 1.16 | 0.97 | 1.15 | 1.28 | 0.65 |
Fiscal Year End for ColgatePalmolive Company falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 966 | 951 | 819 | 867 |
Receivables | NA | 1,586 | 1,577 | 1,656 | 1,590 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1,934 | 1,931 | 2,039 | 2,110 |
Other Current Assets | NA | 793 | 898 | 923 | 899 |
Total Current Assets | NA | 5,279 | 5,357 | 5,437 | 5,466 |
Net Property & Equipment | NA | 4,582 | 4,409 | 4,431 | 4,363 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 214 | 202 | 186 | 179 |
Intangibles | NA | 5,297 | 5,188 | 5,274 | 5,293 |
Deposits & Other Assets | NA | 1,021 | 887 | 899 | 872 |
Total Assets | NA | 16,393 | 16,043 | 16,227 | 16,173 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 310 | 18 | 19 | 22 |
Accounts Payable | NA | 1,698 | 1,482 | 1,544 | 1,609 |
Current Portion Long-Term Debt | NA | 20 | 16 | 16 | 15 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 2,377 | 2,732 | 2,600 | 2,498 |
Income Taxes Payable | NA | 336 | 354 | 453 | 297 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 4,741 | 4,602 | 4,632 | 4,441 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 361 | 430 | 363 | 421 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 8,219 | 8,690 | 8,954 | 8,870 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1,915 | 1,963 | 2,016 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 15,436 | 15,637 | 15,912 | 15,748 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1,466 | 1,466 | 1,466 | 1,466 |
Capital Surplus | NA | 3,808 | 3,762 | 3,688 | 3,603 |
Retained Earnings | NA | 25,289 | 24,571 | 24,258 | 24,153 |
Other Equity | NA | -3,589 | -3,559 | -3,556 | -3,552 |
Treasury Stock | NA | 26,017 | 25,834 | 25,541 | 25,245 |
Total Shareholder's Equity | NA | 957 | 406 | 315 | 425 |
Total Liabilities & Shareholder's Equity | NA | 16,393 | 16,043 | 16,227 | 16,173 |
Total Common Equity | 0 | 957 | 406 | 315 | 425 |
Shares Outstanding | 821.90 | 823.30 | 823.30 | 826.60 | 829.50 |
Book Value Per Share | 0.00 | 1.16 | 0.49 | 0.38 | 0.51 |